References WGB Beta Glucan
1. Onderdonk, AB, Cisneros, RL, et al. Anti-infective of poly-B-1,6-glucotriosly-B 1,3-glucopyranose glucan in vivo. Infection and Immunity.
1992;60:1642-1647
2. Ross, GD, Vetvicka, V, Yan, J, Xia, Y, Vetvickova, J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology.
1999 May;42(1-3):61-74 Review. PMID:10408367 [PubMed-indexed for MEDLINE]
3. Jun Yan, Vaclav Vetvicka, Yu Xia, Angela Coxon, Michael E. Carroll, Tanya N. Mayadas, and Gordon D. Ross. B-Glucan, a "Specific" Biologic Response Modifier That Uses Antibodies to Target Tumors for Cytoxic Recognition by Leukocyte Complement Raceprot Type (CD11b/CD18) J. Immunology 1999;163:3045-3052.
4. Blaylock, R. Yeast B 1,3-glucan and its uses against Anthrax infection and in the treatment of cancer. J American Nutraceutical Ass'n.
v5 n2, Spring 2002.
- Login to post comments






